Feasibility of Exhaled Breath Condensate on Measuring Antibiotic Distribution in Airway Surface Liquid

张静,武晓捷,王琴,宋元林,白春学,张菁,李华茵
DOI: https://doi.org/10.3760/cma.j.issn.1673-436x.2011.012.007
2011-01-01
Abstract:Objective To investigate the feasibility of exhaled breath condensate (EBC) as a sampling technique to evaluate the antibiotic distribution in the airway surface liquid. Methods Six healthy volunteers were enrolled. Before and after 1,2,4,8, 12, and 24 hours of orally taking 500 mg levofloxacin, EBC was collected and the level of levofloxacin was measured by high performance liquid chromatography-fluorescence detection. Results The drug concentration in EBC at each time point after oral administration was 0. 000 (0.000, 0.000), 0.000 (0.000, 0.000), 0.000 (0.000,0.230), 0.000 (0. 000,0. 478), 0. 000 (0. 000,0.173), and 0. 015 (0. 000,0. 095) mg/L. Levofloxacin was undetectable in three of all the six subjects, and that was detectable in the other three subjects after four hours of taking levofloxacin,but there was no dynamic trend of drug concentration with time. No adverse effect was observed during the experiment. Conclusions EBC technology is simple and safe for sampling in airway surface liquid, but the consideration of dilution and low levels of drug concentration preclude EBC to become a promising sampling technique on studying the antibiotic distribution in airway surface liquid.
What problem does this paper attempt to address?